Start an analysis for OPK
Opko Health Inc.
Stock · NASDAQProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $200m | 30-Sep-26 | 10-Q filed 04-Nov-26 |
| Remaining authorization | $84m | 30-Sep-26 | 10-Q filed 04-Nov-26 |
| Program expiry | n/a | — | |
| Repurchased last quarter | $10m | 30-Sep-26 | 10-Q filed 04-Nov-26 |
| Has used an ASR | No | — |
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| 18-Jul-24 | $200m | $84m | n/a | Stock repurchase program originally announced on July 18, 2024, with capacity increased by $100.0 million on April 4, 202510-Q filed 04-Nov-26 |
Open-market repurchases
- Jan ’26
- Feb ’26
- Mar ’26
- Apr ’26
- May ’26
- Jun ’26
- Jul ’26
- Aug ’26
- Sep ’26
| Month ended | Shares | Avg price | ≈ Value | Source |
|---|---|---|---|---|
| 30-Sep-26 | 1,650,000 | $1.61 | $3m | 10-Q filed 04-Nov-26 |
| 31-Aug-26 | 3,950,000 | $1.43 | $6m | 10-Q filed 04-Nov-26 |
| 31-Jul-26 | 1,450,000 | $1.44 | $2m | 10-Q filed 04-Nov-26 |
| 30-Jun-26 | 4,976,000 | $1.45 | $7m | 10-Q filed 28-Aug-26 |